-
Radon in real estate
Radon — an invisible radioactive gas produced by the breakdown of uranium in the ground —is found in every home in Canada. Radon is the #1 cause of lung cancer for non-smokers,... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
This guideline technical document reviews and assesses all identified health risks associated with PFOS in drinking water. It incorporates available studies and approaches and... -
Halifax Indoor Air Quality Study XRF Metals Dataset
In 2009, Health Canada collaborated with Dalhousie University to undertake an indoor air quality study in homes in Halifax, NS. The objective of this study was to better... -
Science Policy Note: Estimating the Water Component of a Dietary Exposure Assessment
This document provides an overview of the policy of Health Canada's Pest Management Regulatory Agency in estimating the concentration of pesticides in potential drinking water... -
Guidance document - Safety and Effectiveness Requirements for Contact Lens...
This guidance document outlines the information considered necessary to support the safety and effectiveness of contact lens disinfectants, which are regulated as medical... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
This guideline technical document was prepared in collaboration with the Federal-Provincial-Territorial Committee on Drinking Water and assesses all available information on... -
Proposed Special Review Decision PSRD2020-05, Special review for Linuron and...
Linuron is an herbicide registered for commercial use in Canada. All currently registered pest control products are considered in this special review (Appendix I). -
Official Method: Determination of Net Contents
1988 Health Canada method to be used to determine the contents of packages as referred to in the Food and Drug Regulations -
Annual Compliance and Enforcement Report Fiscal Year: 2018-2019
To identify, assess, manage, and communicate health or safety risks to Canadians associated with consumer products and cosmetics. -
COVID-19 Food labelling support measures
The Government of Canada is working to respond to challenges raised by the food industry as a result of the COVID-19 pandemic while continuing to ensure that Canadians have... -
Health Canada - Special Committee on the COVID-19 Pandemic - Deputy Head...
Briefing binder for the deputy head of the Minister of Health’s appearances at the Special Committee on the COVID-19 Pandemic (COVI) – Week of January 17 2022 -
Novel food information: Herbicide Tolerant HT4 Maize – MON 87429
Health Canada has notified Bayer CropScience Inc. that it has no objection to the food use of herbicide tolerant HT4 maize – MON 87429. The Department conducted a comprehensive... -
Prochymal: Notice of Compliance with Conditions - Qualifying Notice
Notice of Compliance with Conditions - Qualifying Notice -
Non-prescription Drugs: Labelling Standards - Drug Product
Labelling standards are developed for drugs that have a well characterized safety and efficacy profile under specific conditions of use. A manufacturer may reference a labelling... -
Access to Drugs in Exceptional Circumstances
The Access to Drugs in Exceptional Circumstances regulatory pathway enables access to drugs which have been authorized for sale in certain foreign jurisdictions, but are not... -
Standing Committee on Health
Briefing packages for President, Minister and Deputy Ministers’ Parliamentary Committee appearances. President of the PHAC before the Standing Committee on Health: Canadian... -
Clinical information on drugs and health products
Drug and medical device manufacturers submit clinical information to Health Canada for the approval of new products. Health Canada assesses this clinical information to reach a... -
Registration Decision RD2020-15, Racemic camphor, eucalyptus oil, l-menthol...
This decision is consistent with the Proposed Registration Decision PRD2020-12, Racemic camphor, eucalyptus oil, l-menthol and thymol and Api Life VAR, which contains a detailed... -
Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment... -
Notice of proposal to update the nutrition labelling: Table of reference...
Health Canada's Food Directorate is proposing amendments to the Table of Reference Amounts for Food based on new consumption data and market trends, and to address identified...